LEISHMANIASIS

LEISHMANIASIS was reported 290 times

LEISHMANIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antileishmanial [EPC] 5 0.0129
1 Rifamycin Antimycobacterial [EPC] 8 0.0023
2 Lipid-based Polyene Antifungal [EPC] 27 0.0021
3 CD38-directed Cytolytic Antibody [EPC] 10 0.0017
4 Antimalarial [EPC] 8 0.0008
5 Antiprotozoal [EPC] 8 0.0008
6 Polyene Antifungal [EPC] 27 0.0007
7 Antimetabolite Immunosuppressant [EPC] 11 0.0005
8 SLAMF7-directed Immunostimulatory Antibody [EPC] 2 0.0004
9 Echinocandin Antifungal [EPC] 3 0.0004
10 Protease Inhibitor [EPC] 16 0.0004
11 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0003
12 Cytochrome P450 3A Inhibitor [EPC] 17 0.0003
13 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 10 0.0002
14 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 4 0.0002
15 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 18 0.0002
16 Macrolide Antimicrobial [EPC] 8 0.0002
17 Oxazolidinone Antibacterial [EPC] 4 0.0001
18 Folate Analog Metabolic Inhibitor [EPC] 52 0.0001
19 Penem Antibacterial [EPC] 4 0.0001
20 Tumor Necrosis Factor Blocker [EPC] 104 0.0001
21 Human Immunoglobulin G [EPC] 2 0.0001
22 Purine Antimetabolite [EPC] 8 0.0001
23 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
24 Corticosteroid [EPC] 88 0.0001
25 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0001
26 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 7 0.0001
27 Interleukin-17A Antagonist [EPC] 2 0.0001
28 Pyrimidine Synthesis Inhibitor [EPC] 2 0.0000
29 Insulin [EPC] 2 0.0000
30 Leukocyte Growth Factor [EPC] 6 0.0000
31 Fluoroquinolone Antibacterial [EPC] 5 0.0000
32 Interleukin-12 Antagonist [EPC] 4 0.0000
33 Interleukin-23 Antagonist [EPC] 4 0.0000
34 Azole Antifungal [EPC] 6 0.0000
35 Vitamin B12 [EPC] 12 0.0000
36 Vitamin D [EPC] 11 0.0000
37 Complement Inhibitor [EPC] 2 0.0000
38 Nucleoside Analog Antiviral [EPC] 3 0.0000
39 Iron Chelator [EPC] 1 0.0000
40 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1 0.0000
41 Tetracycline-class Drug [EPC] 2 0.0000
42 Thalidomide Analog [EPC] 14 0.0000
43 Insulin Analog [EPC] 12 0.0000
44 Vitamin C [EPC] 11 0.0000
45 Dihydropyridine Calcium Channel Blocker [EPC] 7 0.0000
46 Hepatitis C Virus NS5A Inhibitor [EPC] 1 0.0000
47 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
48 Alkylating Drug [EPC] 5 0.0000
49 Programmed Death Receptor-1 Blocking Antibody [EPC] 2 0.0000
50 Aminosalicylate [EPC] 2 0.0000
51 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1 0.0000
52 CD20-directed Cytolytic Antibody [EPC] 6 0.0000
53 Antirheumatic Agent [EPC] 2 0.0000
54 Factor Xa Inhibitor [EPC] 5 0.0000
55 Platelet Aggregation Inhibitor [EPC] 10 0.0000
56 Calcineurin Inhibitor Immunosuppressant [EPC] 2 0.0000
57 Glycopeptide Antibacterial [EPC] 1 0.0000
58 Thiazide Diuretic [EPC] 3 0.0000
59 Proton Pump Inhibitor [EPC] 8 0.0000
60 Topoisomerase Inhibitor [EPC] 1 0.0000
61 Nonsteroidal Anti-inflammatory Drug [EPC] 17 0.0000
62 Janus Kinase Inhibitor [EPC] 2 0.0000
63 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
64 Integrin Receptor Antagonist [EPC] 1 0.0000
65 Serotonin Reuptake Inhibitor [EPC] 1 0.0000
66 Mood Stabilizer [EPC] 2 0.0000
67 Anti-epileptic Agent [EPC] 2 0.0000
68 Proteasome Inhibitor [EPC] 1 0.0000
69 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
70 Platinum-based Drug [EPC] 2 0.0000
71 Kinase Inhibitor [EPC] 4 0.0000
72 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
73 Retinoid [EPC] 1 0.0000
74 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
75 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
76 Benzodiazepine [EPC] 1 0.0000